Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia

Neuroscience Letters

Volumn 472, Issue 3, 2010, Pages 184-187

  Nishiyori, Michiko ^a   Nagai, Jun ^a   Nakazawa, Takahiro ^b   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Fibromyalgia; Hyperalgesia; Intermittent cold stress; Morphine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; MORPHINE; SEROTONIN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FIBROMYALGIA; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SPINAL CORD;

ANIMALS; COLD TEMPERATURE; FIBROMYALGIA; HYDROXYINDOLEACETIC ACID; INJECTIONS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NARCOTICS; SEROTONIN; SPINAL CORD; STRESS, PHYSIOLOGICAL;

EID: 77649275603     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.080     Document Type: Article

References (44)

1. Abeles M., Solitar B.M., Pillinger M.H., and Abeles A.M. Update on fibromyalgia therapy. Am. J. Med. 121 (2008) 555-561
2. Arner S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
3. Arnold L.M., Hudson J.I., Hess E.V., Ware A.E., Fritz D.A., Auchenbach M.B., Starck L.O., and Keck Jr. P.E. Family study of fibromyalgia. Arthritis Rheum. 50 (2004) 944-952
4. Buskila D., and Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res. Ther. 8 (2006) 218
5. Cassisi G., Sarzi-Puttini P., Alciati A., Casale R., Bazzichi L., Carignola R., Gracely R.H., Salaffi F., Marinangeli F., Torta R., Giamberardino M.A., Buskila D., Spath M., Cazzola M., Di Franco M., Biasi G., Stisi S., Altomonte L., Arioli G., Leardini G., Gorla R., Marsico A., Ceccherelli F., and Atzeni F. Symptoms and signs in fibromyalgia syndrome. Reumatismo 60 Suppl. 1 (2008) 15-24
6. Clauw D.J. Pharmacotherapy for patients with fibromyalgia. J. Clin. Psychiatry 69 Suppl. 2 (2008) 25-29
7. Dogrul A., Ossipov M.H., and Porreca F. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res. 1280 (2009) 52-59
8. Fadda P., Scherma M., Fresu A., Collu M., and Fratta W. Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice. Synapse 56 (2005) 29-38
9. Fields H.L., Basbaum A.I., and Heinricher M.M. Central nervous system mechanisms of pain modulation. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's Textbook of Pain. 5th ed. (2006), Churchill Livingstone (Elsevier), Philadelphia 125-142
10. Gore M., Sadosky A.B., Zlateva G., and Clauw D.J. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin. Pain Pract. (2009)
11. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
12. Harris R.E., Clauw D.J., Scott D.J., McLean S.A., Gracely R.H., and Zubieta J.K. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 27 (2007) 10000-10006
13. Hauser W., Bernardy K., Uceyler N., and Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin-a meta-analysis of randomized controlled trials. Pain (2009)
14. Heinricher M.M., McGaraughty S., and Farr D.A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81 (1999) 57-65
15. Hylden J.L., and Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67 (1980) 313-316
16. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., and Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10 (2004) 712-718
17. Khasar S.G., Dina O.A., Green P.G., and Levine J.D. Sound stress-induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines. J. Pain (2009)
18. Khasar S.G., Miao J.P., Janig W., and Levine J.D. Modulation of bradykinin-induced mechanical hyperalgesia in the rat by activity in abdominal vagal afferents. Eur. J. Neurosci. 10 (1998) 435-444
19. Kupers R.C., Konings H., Adriaensen H., and Gybels J.M. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 47 (1991) 5-12
20. Lautenschlager J. Present state of medication therapy in fibromyalgia syndrome. Scand. J. Rheumatol. Suppl. 113 (2000) 32-36
21. Maizels M., and McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am. Fam. Physician 71 (2005) 483-490
22. Mason P. Physiological identification of pontomedullary serotonergic neurons in the rat. J. Neurophysiol. 77 (1997) 1087-1098
23. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
24. Nakazawa T., Yasuda T., Ueda J., and Ohsawa K. Antidepressant-like effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol. Pharm. Bull. 26 (2003) 474-480
25. Nishiyori M., and Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol. Pain 4 (2008) 52
26. Pan Z.Z., and Fields H.L. Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience 74 (1996) 855-862
27. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25 (2002) 319-325
28. Rao S.G., and Bennett R.M. Pharmacological therapies in fibromyalgia. Best Pract. Res. Clin. Rheumatol. 17 (2003) 611-627
29. Rao S.G., and Clauw D.J. The management of fibromyalgia. Drugs Today (Barc) 40 (2004) 539-554
30. Rashid M.H., Inoue M., Toda K., and Ueda H. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J. Pharmacol. Exp. Ther. 309 (2004) 380-387
31. Seltzer Z., Dubner R., and Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 (1990) 205-218
32. Sluka K.A., Kalra A., and Moore S.A. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24 (2001) 37-46
33. Sommer C., Hauser W., Gerhold K., Joraschky P., Petzke F., Tolle T., Uceyler N., Winkelmann A., and Thieme K. Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain. Schmerz 22 (2008) 267-282
34. Sorensen J., Bengtsson A., Backman E., Henriksson K.G., and Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand. J. Rheumatol. 24 (1995) 360-365
35. Staud R. Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res. Ther. 8 (2006) 208
36. Su S.Y., Chen J.J., Lai C.C., Chen C.M., and Tsai F.J. The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin. Rheumatol. 26 (2007) 12-16
37. Sumpton J.E., and Moulin D.E. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res. Manag. 13 (2008) 477-483
38. Tander B., Gunes S., Boke O., Alayli G., Kara N., Bagci H., and Canturk F. Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility. Rheumatol. Int. 28 (2008) 685-691
39. Tao R., and Auerbach S.B. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J. Neurochem. 63 (1994) 517-524
40. Taylor B.K., and Basbaum A.I. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray. J. Neurochem. 86 (2003) 1129-1141
41. Ueda H. Peripheral mechanisms of neuropathic pain-involvement of lysophosphatidic acid receptor-mediated demyelination. Mol. Pain 4 (2008) 11
42. Ueda H., and Ueda M. Mechanisms underlying morphine analgesic tolerance and dependence. Front. Biosci. 14 (2009) 5260-5272
43. Weitemier A.Z., and Murphy N.P. Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion. Eur. J. Neurosci. 29 (2009) 1015-1026
44. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110